SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-18-052119
Filing Date
2018-08-15
Accepted
2018-08-15 07:12:08
Documents
6
Effectiveness Date
2018-08-15

Document Format Files

Seq Description Document Type Size
1 S-8 POS a18-18716_3s8pos.htm S-8 POS 115593
2 EX-5.1 a18-18716_3ex5d1.htm EX-5.1 10951
3 EX-23.1 a18-18716_3ex23d1.htm EX-23.1 3066
4 GRAPHIC g187163kki001.jpg GRAPHIC 5605
5 GRAPHIC g187163kki002.gif GRAPHIC 5049
6 GRAPHIC g187163kki003.jpg GRAPHIC 2209
  Complete submission text file 0001104659-18-052119.txt   148892
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-224924 | Film No.: 181019718
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1